Patient Treatment

Showing: 1 - 2 of 2 Articles

Allogenic Regenerative Cell Therapy for End-Stage Liver Disease

E-Health Innovations

LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease

LyGenesis, a clinical-stage biotechnology company developing cell therapies for large unmet medical needs, announced today …

vinay April 3, 2024April 3, 2024

Device Innovations

Endovascular Engineering’s Hēlo™ Thrombectomy System Receives IDE Approval to Start ENGULF Pivotal Trial for the Treatment of Pulmonary Embolism

Endovascular Engineering (“E2”), a medical device company focused on the development and deployment of groundbreaking …

vinay January 11, 2024January 11, 2024